Core Insights - Fangzhou Inc. has been awarded the "AI-Powered Future Award" by Tencent Health, highlighting its leadership in AI-driven chronic disease services and digital healthcare transformation [1][5]. Company Overview - Fangzhou is recognized as one of China's leading platforms for AI-enabled chronic care, focusing on technology as a primary growth driver [3]. - As of June 30, 2025, the company serves 52.8 million registered users and 229,000 physicians, specializing in tailored medical care and AI-enabled precision medicine solutions [10]. Strategic Developments - In 2025, Fangzhou upgraded its Hospital-to-Home (H2H) model to an "AI + H2H" smart healthcare ecosystem, emphasizing long-term doctor-patient relationships as a key differentiator in chronic disease management [3]. - The company has expanded its Medicine as a Service (MaaS) framework, integrating patient trust with service delivery capabilities to create scalable chronic disease management solutions [4]. Collaboration and Technology - The partnership with Tencent Health has been crucial, combining Fangzhou's domain knowledge with Tencent's cloud computing and AI infrastructure to establish a replicable model for intelligent chronic care services [6]. Performance Metrics - Fangzhou's AI-driven model has improved healthcare delivery by overcoming traditional constraints, leading to increased user engagement and platform activity [7]. - The company has issued a positive profit alert, forecasting 2025 revenue between RMB 3.5 billion and RMB 3.55 billion, indicating approximately 30% year-on-year growth [8]. Future Outlook - Fangzhou plans to further strengthen its MaaS system, enhance AI integration in chronic disease services, and expand access to technology-enabled care, solidifying its role in China's healthcare digitization [9].